Related Experiment Video
Updated: Oct 5, 2025
An Ex Vivo Tissue Culture Model of Cartilage Remodeling in Bovine Knee Explants
Published on: November 3, 2019
The collagenases: are they tractable targets for preventing cartilage destruction in osteoarthritis?
Tuomo Karila1,2, Taina Tervahartiala3, Beniamin Cohen4
1Hospital Orton, Helsinki, Finland.
Introduction:
The etiology and pathogenesis of osteoarthritis (OA) have been intensely investigated; however, the disease course and progression are not completely understood. A prominent role for interstitial collagenases is recognized in this degenerative process; hence, strategies to target them are of major interest.
Areas Covered:
The pathogenesis of OA, the role of interstitial collagenases (MMP-1, -8, and -13), and collagenase modifying drugs are examined and discussed. We reviewed relevant papers from PubMed and Google Scholar.
Expert Opinion:
There is strong evidence for the therapeutic potential of MMP inhibitors in OA; however, they are not expected to impact the inflammatory process. Therefore, there is a need for a relative inhibitor of MMP-13 collagenase, which possesses anti-inflammatory properties. The identification of novel broad-spectrum relative to multiple peptidase inhibitors could provide desirable tools for the prophylaxis, cure, or treatment of diseases involving articular cartilage (AC) degradation, in particular OA.
Insights
Osteoarthritis (OA) involves interstitial collagenases. While matrix metalloproteinase (MMP) inhibitors show therapeutic potential, a specific MMP-13 inhibitor with anti-inflammatory properties is needed for treating articular cartilage degradation in OA.
Area of Science:
- Biochemistry
- Rheumatology
- Pharmacology
Background:
- Osteoarthritis (OA) pathogenesis is not fully understood, despite extensive research.
- Interstitial collagenases, including matrix metalloproteinases (MMPs) -1, -8, and -13, play a significant role in OA's degenerative processes.
- Targeting these collagenases is a key area of interest for OA treatment strategies.
Purpose of the Study:
- To examine the pathogenesis of OA, focusing on the role of interstitial collagenases (MMP-1, -8, and -13).
- To discuss existing and potential collagenase-modifying drugs for OA.
- To identify needs for novel therapeutic agents targeting articular cartilage degradation.
Main Methods:
- Literature review of relevant papers from PubMed and Google Scholar.
- Analysis of the role of interstitial collagenases in osteoarthritis pathogenesis.
- Discussion of therapeutic strategies involving MMP inhibitors.
Main Results:
- Strong evidence supports the therapeutic potential of MMP inhibitors in OA.
- Current MMP inhibitors are not expected to significantly impact the inflammatory component of OA.
- A need exists for selective MMP-13 inhibitors with anti-inflammatory properties.
Conclusions:
- Novel broad-spectrum peptidase inhibitors could offer new tools for preventing and treating diseases involving articular cartilage degradation, particularly OA.
- Targeted inhibition of MMP-13, combined with anti-inflammatory effects, is a promising avenue for OA therapy.
- Further research into selective MMP inhibitors is crucial for developing effective OA treatments.
